Innate immune memory is associated with increased disease-free survival in bladder cancer patients treated with bacillus Calmette-Guerin.

Citation metadata

From: Canadian Urological Association Journal(Vol. 15, Issue 8)
Publisher: Canadian Urological Association
Document Type: Report
Length: 3,722 words
Lexile Measure: 1790L

Document controls

Main content

Abstract :

Introduction: While studies suggest that innate immune memory acquired by circulating monocytes may mediate the benefit of bacillus Calmette-Guerin (BCG) in the treatment of patients with high-risk non-muscle-invasive bladder cancer (NMIBC), prospective studies are lacking. Innate immune memory is defined by enhanced release of pro-inflammatory cytokines by innate immune cells following a secondary challenge with pattern recognition receptor (PRR) ligands. Methods: Peripheral blood monocytes isolated from 33 patients with intermediate- or high-risk NMIBC before and after two or five induction BCG instillations were stimulated with the PRR ligand lipopolysaccharide (LPS). Inflammatory cytokine levels in the culture medium were measured. Extent of innate immune memory acquisition was determined by dividing the levels of cytokines released after BCG instillation by the levels released prior to BCG therapy. Results: Monocytes secreted variable levels of TNF[alpha], IL-1[beta], IL-6, IFN[gamma], IL-12, and IL-10. Compared with patients with recurrences, the post-BCGpre-BCG ratio of IL-12 in monocyte cultures from patients without recurrences after five BCG instillations was significantly increased. Patients with no innate immune memory (based on IL-12 ratios) had significantly shorter times-to-recurrence than patients with innate immune memory (p Conclusion: Results demonstrate a potential link between BCG-induced innate immune memory peripherally and local anti-tumor responses. Further validation will increase our understanding of the mode of action of BCG and, therefore, will be used to enhance its effectiveness.

Source Citation

Source Citation   

Gale Document Number: GALE|A660099654